Text size :

Health, Scala (Aipo): “3.5 million Italians with COPD, 100,000 hospitalizations a year”

ADNKRONOS

November 10, 2026

Rome, 10 Nov. (Adnkronos Health) – “COPD – chronic obstructive pulmonary disease – is a disease that we can define as pandemic: in Italy, an estimated 3.5 million patients suffer from this pathology, especially in middle to advanced age. The economic-health impact is also significant: almost 100,000 hospitalizations are recorded annually, and unfortunately, one-third of these people do not survive the episode.” This was stated by Raffaele Scala, president of Aipo – Italian Association of Hospital Pulmonologists and director of the Pneumology and UTIP Unit at San Donato Hospital in Arezzo, during the meeting ‘Respiratory health in Italy and therapeutic innovation. Towards a shared roadmap for severe asthma, COPD, and nasal polyposis’, held today at the Senate Library in Rome.

“The needs of people with COPD are enormous – Scala continues – When ‘air hunger’ appears, it means the disease is already very advanced. It is therefore an unmet need that also depends on an inadequate application of all the tools and innovations we have available to control the evolution of the disease. COPD should indeed be considered a time-dependent pathology: the sooner we intercept it, the greater the tools available and the chances of preventing its evolution. In this sense – he observes – technological innovation, most recently that linked to the introduction of biological drugs, which have revolutionized and are revolutionizing the treatment of COPD, is certainly very important. However, if this innovation is not integrated into an organizational context that involves a close correlation between pneumology specialists and general practitioners, and that allows for the creation of a truly interconnected network between the territory and the hospital, it will not be able to express its full potential demonstrated in clinical studies.”

“It all lies in creating synergy among the various healthcare actors and professionals, institutions, patient associations, and various stakeholders, including private ones, who must contribute in this regard. The last point I wanted to emphasize – he adds – concerns exacerbation, a truly dramatic episode for those suffering from this type of pathology, because the patient has the sensation of failing, of possibly dying, but also for caregivers, who may experience depressive syndromes as a result. People need to know that there is a safe place to refer to, not only in the territory but also in the hospital, where acute respiratory attacks are managed – states the expert – What is unfortunately still missing, and which we do have for other important pathologies like cardiac ones, such as heart attack or stroke, is a place dedicated to ‘lungs attack’, the respiratory attack: it does not yet exist. Pneumological intensive care units are needed so that a person affected by a severe acute respiratory attack can have the same dignity and equity of care guaranteed to someone suffering a cardiac attack. Technological innovation and the introduction of biological drugs are excellent – he concludes – but all this must be placed within a framework where these people are not considered to be affected by a neglected pathology.”

Jiji Press

Related

Page TOP